Current Operating Procedure (COP) for Bleomycin ElectroScleroTherapy (BEST) of low-flow vascular malformations

Current Operating Procedure (COP) for Bleomycin ElectroScleroTherapy (BEST) of low-flow vascular malformations

Bleomycin ElectroScleroTherapy (BEST) is a new approach in the treatment of vascular malformations. After bleomycin is administered to the malformation, electric pulses are applied to the target area to enhance the effectiveness of bleomycin. The mode of action is comparable to the effect of electro...

Full description

Saved in:
Bibliographic Details
Main Authors: Muir Tobian, Wohlgemuth Walter A, Cemazar Maja, Bertino Giulia, Groselj Ales, Ratnam Lakshmi A, McCafferty Ian, Wildgruber Moritz, Gebauer Bernhard, de Terlizzi Francesca, Zanasi Alessandro, Sersa Gregor
Format: Article
Language:English
Published: Sciendo 2024-11-01
Series:Radiology and Oncology
Subjects:
low-flow vascular malformations
bleomycin sclerotherapy
bleomycin electrosclerotherapy
best
Online Access:https://doi.org/10.2478/raon-2024-0061
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Bleomycin ElectroScleroTherapy (BEST) is a new approach in the treatment of vascular malformations. After bleomycin is administered to the malformation, electric pulses are applied to the target area to enhance the effectiveness of bleomycin. The mode of action is comparable to the effect of electrochemotherapy on tumour vasculature. For the wider and safer use of BEST in the clinical treatment of low-flow vascular malformations, this Current Operating Procedure (COP) is being prepared. It is a proposal for the clinical standardisation of BEST using the Cliniporator® as the electrical pulse generator with its associated electrodes. The electrical parameters considered in this protocol are those validated by the European Standard Operating Procedures for Electrochemotherapy (ESOPE) with the Cliniporator®.
ISSN:1581-3207

Similar Items